20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Kirkland, United States with about 443 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2026-04-30, KMTS reported $95M in revenue and ($132M) in net income.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights.
Interactive charts & full statements → Open the KMTS valuation workbench →
| Income statement | TTM → 2026-07-31 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 | 2020-04-30 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $107M | $95M | $60M | $28M | $8M | $0M | $0M |
| Gross Profit | $58M | $49M | $24M | $0M | ($11M) | — | — |
| Gross Margin % | 53.9% | 51.4% | 40.5% | 1.3% | -139.6% | — | — |
| Operating Income (EBIT) | ($144M) | ($135M) | ($106M) | ($85M) | ($80M) | ($33M) | ($29M) |
| Operating Margin % | -134.5% | -141.6% | -177.8% | -305.8% | -1054.0% | — | — |
| Net Income | ($150M) | ($132M) | ($114M) | ($94M) | ($84M) | ($34M) | ($29M) |
| Net Margin % | -140.4% | -138.3% | -190.3% | -338.4% | -1104.0% | — | — |
| EBITDA | ($147M) | ($150M) | ($98M) | ($76M) | ($74M) | ($32M) | ($29M) |
| Earnings Per Share (EPS) | — | $-2.25 | $-2.30 | $-1.90 | $-1.70 | $-0.69 | $-0.59 |
| Shares Outstanding (M) | 58M | 58M | 50M | 50M | 50M | 50M | 50M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $31M | $29M | $25M | $23M | $19M | $17M | $15M | $15M |
| Gross Profit | $17M | $16M | $13M | $11M | $9M | $8M | $7M | $6M |
| Gross Margin % | 56.5% | 54.8% | 52.6% | 50.6% | 45.7% | 44.3% | 43.4% | 39.6% |
| Operating Income (EBIT) | ($38M) | ($39M) | ($35M) | ($32M) | ($29M) | ($48M) | ($21M) | ($19M) |
| Operating Margin % | -121.6% | -137.4% | -141.6% | -140.7% | -149.1% | -279.8% | -136.5% | -130.1% |
| Net Income | ($44M) | ($39M) | ($34M) | ($33M) | ($26M) | ($52M) | ($22M) | ($20M) |
| Net Margin % | -142.3% | -135.6% | -139.2% | -145.3% | -133.3% | -302.1% | -142.5% | -138.5% |
| EBITDA | ($38M) | ($50M) | ($30M) | ($28M) | ($22M) | ($47M) | ($18M) | ($17M) |
| Earnings Per Share (EPS) | — | $-0.67 | $-0.65 | $-0.64 | $-0.50 | $-1.05 | $-0.43 | $-0.41 |
| Shares Outstanding (M) | — | 58M | 53M | 51M | 51M | 50M | 50M | 50M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-04-30 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 | 2020-04-30 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($82M) | ($82M) | ($78M) | ($72M) | ($70M) | ($30M) | ($30M) |
| Capital Expenditures (CapEx) | $35M | $35M | $24M | $13M | $15M | $0M | $0M |
| Free Cash Flow (FCF) | ($117M) | ($117M) | ($101M) | ($85M) | ($85M) | ($30M) | ($31M) |
| FCF Margin % | -109.2% | -122.6% | -169.2% | -304.7% | -1115.4% | — | — |
| Dividends Paid | $0M | $0M | $2M | $1M | $1M | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($32M) | ($19M) | ($18M) | ($18M) | ($26M) | ($24M) | ($18M) | ($18M) | ($17M) |
| Capital Expenditures (CapEx) | $8M | $10M | $10M | $7M | $8M | $8M | $4M | $4M | $7M |
| Free Cash Flow (FCF) | ($41M) | ($28M) | ($28M) | ($26M) | ($34M) | ($32M) | ($22M) | ($22M) | ($25M) |
| FCF Margin % | — | -99.1% | -114.7% | -113.5% | -177.8% | -184.2% | -149.0% | -152.6% | — |
| Dividends Paid | — | $0M | $0M | $0M | $0M | $0M | $0M | $1M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-04-30 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 | 2020-04-30 |
|---|---|---|---|---|---|---|---|
| Total Assets | $358M | $358M | $296M | $46M | $39M | $31M | $8M |
| Cash & Cash Equivalents | $100M | $100M | $238M | $8M | $15M | $24M | $6M |
| Total Liabilities | $99M | $99M | $90M | $255M | $156M | $29M | $4M |
| Total Debt (Short + Long-Term) | $43M | $43M | $41M | $43M | $39M | $21M | $0M |
| Total Shareholders' Equity | $260M | $260M | $205M | ($209M) | ($118M) | $2M | $4M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KMTS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms